A Phase IB, Open-Label, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of UTTR1147A in Combination with Standard of Care in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Brief Summary

Type:
Leukemias

Study Type:
Prevention

Phase:
I

ClinicalTrials.gov Identifier:
NCT04539470

Study #:
STUDY00145179

Start Date:
Nov 02, 2020

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04539470

View Complete Trial Details & Eligibility at ClinicalTrials.gov